Carcinogenesis, Vol. 22, No. 1, 1-3,
January 2001
© 2001 Oxford University Press
ACCELERATED PAPER |
Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity
Department of Oncological Pathology, Cancer Center, Nara Medical University, 840, Shijo-cho, Kashihara, Nara 634-8521,
1 Biochemistry Division, National Cancer Center Research Institute, 1-1 Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045 and
2 Chugai Pharmaceutical Co. Ltd, 1-135 Komakado, Gotemba, Shizuoka 412-0038, Japan
The involvement of poly(ADP-ribose) polymerase-1 (Parp-1), one of the poly(ADP-ribose) polymerase family proteins, in genomic stability, DNA repair and cell death triggered by DNA damage has been well documented. However, the potential role of Parp-1 in carcinogenesis has not been well evaluated. In this study the carcinogenic activity of N-nitrosobis(2-hydroxypropyl)amine (BHP) was studied in Parp-1/ mice, generated by disrupting Parp-1 gene exon 1. Parp-1/ and Parp-1+/+ male mice received 0, 250 and 500 p.p.m. BHP in their drinking water for 20 weeks and were then killed. The percentage of animals bearing hemangiomas and hemangiosarcomas in the liver and numbers of tumors per mouse were markedly higher in the Parp-1/ groups given 250 or 500 p.p.m. BHP than in their Parp-1+/+ counterparts. Hemangiosarcomas developed only in Parp-1/ mice. In the lung the numbers of adenomas per mouse were increased in Parp-1/ mice given BHP at 250 and 500 p.p.m. (P < 0.01) compared with the Parp-1+/+ case. The results show that susceptibility to BHP is significantly elevated in Parp-1/ mice, thus providing direct evidence that Parp-1 is relevant to carcinogenesis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Landi, F. Gemignani, F. Canzian, V. Gaborieau, R. Barale, D. Landi, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, et al. DNA Repair and Cell Cycle Control Genes and the Risk of Young-Onset Lung Cancer. Cancer Res., November 15, 2006; 66(22): 11062 - 11069. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Raval-Fernandes, V. A. Kickhoefer, C. Kitchen, and L. H. Rome Increased Susceptibility of Vault Poly(ADP-Ribose) Polymerase-Deficient Mice to Carcinogen-Induced Tumorigenesis Cancer Res., October 1, 2005; 65(19): 8846 - 8852. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Kim, T. Zhang, and W. L. Kraus Poly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD+ into a nuclear signal Genes & Dev., September 1, 2005; 19(17): 1951 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shiokawa, M. Masutani, H. Fujihara, K. Ueki, R. Nishikawa, T. Sugimura, H. Kubo, and H. Nakagama Genetic Alteration of Poly(ADP-ribose) Polymerase-1 in Human Germ Cell Tumors Jpn. J. Clin. Oncol., February 1, 2005; 35(2): 97 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lebel, J. Lavoie, I. Gaudreault, M. Bronsard, and R. Drouin Genetic Cooperation between the Werner Syndrome Protein and Poly(ADP-Ribose) Polymerase-1 in Preventing Chromatid Breaks, Complex Chromosomal Rearrangements, and Cancer in Mice Am. J. Pathol., May 1, 2003; 162(5): 1559 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Tong, H. Ohgaki, H. Huang, C. Granier, P. Kleihues, and Z.-Q. Wang Null Mutation of DNA Strand Break-Binding Molecule Poly(ADP-ribose) Polymerase Causes Medulloblastomas in p53-/- Mice Am. J. Pathol., January 1, 2003; 162(1): 343 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Tong, U. Cortes, M. P. Hande, H. Ohgaki, L. R. Cavalli, P. M. Lansdorp, B. R. Haddad, and Z.-Q. Wang Synergistic Role of Ku80 and Poly(ADP-ribose) Polymerase in Suppressing Chromosomal Aberrations and Liver Cancer Formation Cancer Res., December 1, 2002; 62(23): 6990 - 6996. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Masutani and M. Miwa Poly(ADP-ribose) Polymerase and Cancer: In Relation to the Lectures Presented by Dr Gilbert de Murcia Jpn. J. Clin. Oncol., November 1, 2002; 32(11): 483 - 487. [Full Text] [PDF] |
||||
![]() |
L. Virag and C. Szabo The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors Pharmacol. Rev., September 1, 2002; 54(3): 375 - 429. [Abstract] [Full Text] [PDF] |
||||




